News

News

Icon LISA News = LISA News
08.11.2018
Valneva Reports Nine Month Results for 2018, Confirms Guidance, Strengthens Balance Sheet with €50m Financing
07.11.2018
Themis Bioscience Publishes Compelling Phase 2 Results for Lead Vaccine Candidate against Chikungunya Fever in the Lancet
05.11.2018
EANS-News: Marinomed Biotech AG / Marinomed announces its intention to launch an Initial Public Offering and listing on the Vienna Stock Exchange
29.10.2018
ACIB: Targeting cancer
25.10.2018
Lexogen supports thousands of RNA researchers worldwide by partnering with the RNA Society in their 2018/19 RNA Salon initiative
25.10.2018
Valneva Receives Positive Feedback from EMA on its further Development for Lyme Disease Vaccine VLA15
19.10.2018
Valneva Announces Progress of Chikungunya Vaccine
19.10.2018
Themis Bioscience Announces Exclusive Licensing Agreement with Max- Planck-Innovation to Develop and Commercialize Oncolytic Virotherapies Themis to expand measles vector immunomodulation portfolio into oncology indications
19.10.2018
Nanocages in the lab and in the computer: how DNA-based dendrimers transport nanoparticles
19.10.2018
TÜV AUSTRIA Wissenschaftspreis-Shortlist 2018 Die Kandidaten für den diesjährigen Wissenschaftspreis stehen fest